248 related articles for article (PubMed ID: 24651679)
1. Macrophage inflammatory markers are associated with subclinical carotid artery disease in women with human immunodeficiency virus or hepatitis C virus infection.
Shaked I; Hanna DB; Gleißner C; Marsh B; Plants J; Tracy D; Anastos K; Cohen M; Golub ET; Karim R; Lazar J; Prasad V; Tien PC; Young MA; Landay AL; Kaplan RC; Ley K
Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1085-92. PubMed ID: 24651679
[TBL] [Abstract][Full Text] [Related]
2. Subclinical cardiovascular disease in HIV controller and long-term nonprogressor populations.
Brusca RM; Hanna DB; Wada NI; Blankson JN; Witt MD; Jacobson LP; Kingsley L; Palella FJ; Budoff M; Brown TT; Anastos K; Lazar JM; Mack WJ; Bacchetti P; Tien PC; Golzar Y; Plankey M; Golub E; Kaplan RC; Post WS
HIV Med; 2020 Apr; 21(4):217-227. PubMed ID: 31729142
[TBL] [Abstract][Full Text] [Related]
3. Association of Macrophage Inflammation Biomarkers With Progression of Subclinical Carotid Artery Atherosclerosis in HIV-Infected Women and Men.
Hanna DB; Lin J; Post WS; Hodis HN; Xue X; Anastos K; Cohen MH; Gange SJ; Haberlen SA; Heath SL; Lazar JM; Liu C; Mack WJ; Ofotokun I; Palella FJ; Tien PC; Witt MD; Landay AL; Kingsley LA; Tracy RP; Kaplan RC
J Infect Dis; 2017 May; 215(9):1352-1361. PubMed ID: 28199691
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein(a) and HIV: Allele-Specific Apolipoprotein(a) Levels Predict Carotid Intima-Media Thickness in HIV-Infected Young Women in the Women's Interagency HIV Study.
Enkhmaa B; Anuurad E; Zhang W; Li CS; Kaplan R; Lazar J; Merenstein D; Karim R; Aouizerat B; Cohen M; Butler K; Pahwa S; Ofotokun I; Adimora AA; Golub E; Berglund L
Arterioscler Thromb Vasc Biol; 2017 May; 37(5):997-1004. PubMed ID: 28336560
[TBL] [Abstract][Full Text] [Related]
5. Soluble TWEAK may predict carotid atherosclerosis in treated HIV infection.
Dirajlal-Fargo S; Sattar A; Kulkarni M; Funderburg N; McComsey GA
HIV Clin Trials; 2017 Jul; 18(4):156-163. PubMed ID: 28828963
[TBL] [Abstract][Full Text] [Related]
6. Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection.
Mascia C; Lichtner M; Zuccalà P; Vita S; Tieghi T; Marocco R; Savinelli S; Rossi R; Iannetta M; Campagna M; Schiavone F; Mengoni F; Russo G; Mastroianni CM; Vullo V
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):644-655. PubMed ID: 28578937
[TBL] [Abstract][Full Text] [Related]
7. Plasma Biomarkers of Human Immunodeficiency Virus-Related Systemic Inflammation and Immune Activation in Sub-Saharan Africa Before and During Suppressive Antiretroviral Therapy.
Kroeze S; Wit FW; Rossouw TM; Steel HC; Kityo CM; Siwale M; Akanmu S; Mandaliya K; de Jager M; Ondoa P; Reiss P; Rinke de Wit TF; Kootstra N; Hamers RL
J Infect Dis; 2019 Aug; 220(6):1029-1033. PubMed ID: 31086991
[TBL] [Abstract][Full Text] [Related]
8. Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients.
Burdo TH; Lo J; Abbara S; Wei J; DeLelys ME; Preffer F; Rosenberg ES; Williams KC; Grinspoon S
J Infect Dis; 2011 Oct; 204(8):1227-36. PubMed ID: 21917896
[TBL] [Abstract][Full Text] [Related]
9. During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV Therapy.
Kostadinova L; Shive CL; Judge C; Zebrowski E; Compan A; Rife K; Hirsch A; Falck-Ytter Y; Schlatzer DM; Li X; Chance MR; Rodriguez B; Popkin DL; Anthony DD
J Infect Dis; 2016 Nov; 214(9):1438-1448. PubMed ID: 27540113
[TBL] [Abstract][Full Text] [Related]
10. The CD163-expressing macrophages recognize and internalize TWEAK: potential consequences in atherosclerosis.
Moreno JA; Muñoz-García B; Martín-Ventura JL; Madrigal-Matute J; Orbe J; Páramo JA; Ortega L; Egido J; Blanco-Colio LM
Atherosclerosis; 2009 Nov; 207(1):103-10. PubMed ID: 19473660
[TBL] [Abstract][Full Text] [Related]
11. Soluble CD14, CD163, and CD27 biomarkers distinguish ART-suppressed youth living with HIV from healthy controls.
Williams JC; Zhang X; Karki M; Chi YY; Wallet SM; Rudy BJ; Nichols SL; Goodenow MM; Sleasman JW
J Leukoc Biol; 2018 Apr; 103(4):671-680. PubMed ID: 29377283
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory Obesity Phenotypes, Gender Effects, and Subclinical Atherosclerosis in African Americans: The Jackson Heart Study.
Lin A; Lacy ME; Eaton C; Correa A; Wu WC
Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2431-2438. PubMed ID: 27856456
[TBL] [Abstract][Full Text] [Related]
13. Loss of CXCR4 on non-classical monocytes in participants of the Women's Interagency HIV Study (WIHS) with subclinical atherosclerosis.
Mueller KAL; Hanna DB; Ehinger E; Xue X; Baas L; Gawaz MP; Geisler T; Anastos K; Cohen MH; Gange SJ; Heath SL; Lazar JM; Liu C; Mack WJ; Ofotokun I; Tien PC; Hodis HN; Landay AL; Kaplan RC; Ley K
Cardiovasc Res; 2019 May; 115(6):1029-1040. PubMed ID: 30520941
[TBL] [Abstract][Full Text] [Related]
14. Reduced sTWEAK and increased sCD163 levels in HIV-infected patients: modulation by antiretroviral treatment, HIV replication and HCV co-infection.
Beltrán LM; Muñoz Hernández R; de Pablo Bernal RS; García Morillo JS; Egido J; Noval ML; Ferrando-Martinez S; Blanco-Colio LM; Genebat M; Villar JR; Moreno-Luna R; Moreno JA
PLoS One; 2014; 9(3):e90541. PubMed ID: 24594990
[TBL] [Abstract][Full Text] [Related]
15. Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection.
Lidofsky A; Holmes JA; Feeney ER; Kruger AJ; Salloum S; Zheng H; Seguin IS; Altinbas A; Masia R; Corey KE; Gustafson JL; Schaefer EA; Hunt PW; Deeks S; Somsouk M; Chew KW; Chung RT; Alatrakchi N
J Infect Dis; 2018 Sep; 218(9):1394-1403. PubMed ID: 29868909
[TBL] [Abstract][Full Text] [Related]
16. Noncalcified coronary atherosclerotic plaque and immune activation in HIV-infected women.
Fitch KV; Srinivasa S; Abbara S; Burdo TH; Williams KC; Eneh P; Lo J; Grinspoon SK
J Infect Dis; 2013 Dec; 208(11):1737-46. PubMed ID: 24041790
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of subclinical atherosclerosis is increased in systemic sclerosis and is associated with serum proteins: a cross-sectional, controlled study of carotid ultrasound.
Schiopu E; Au KM; McMahon MA; Kaplan MJ; Divekar A; Singh RR; Furst DE; Clements PJ; Ragvendra N; Zhao W; Maranian P; Khanna D
Rheumatology (Oxford); 2014 Apr; 53(4):704-13. PubMed ID: 24357811
[TBL] [Abstract][Full Text] [Related]
18. Macrophage Activation and the Tumor Necrosis Factor Cascade in Hepatitis C Disease Progression Among HIV-Infected Women Participating in the Women's Interagency HIV Study.
French AL; Martin JW; Evans CT; Peters M; Kessaye SG; Nowicki M; Kuniholm M; Golub E; Augenbraun M; Desai SN;
J Acquir Immune Defic Syndr; 2017 Dec; 76(4):438-444. PubMed ID: 29077674
[TBL] [Abstract][Full Text] [Related]
19. Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1-HCV co-infected patients on effective combined anti-HIV treatment.
Parisi SG; Andreis S; Mengoli C; Menegotto N; Cavinato S; Scaggiante R; Andreoni M; Palù G; Basso M; Cattelan AM
Med Microbiol Immunol; 2018 Aug; 207(3-4):183-194. PubMed ID: 29523966
[TBL] [Abstract][Full Text] [Related]
20. Reduced CD14 expression on classical monocytes and vascular endothelial adhesion markers independently associate with carotid artery intima media thickness in chronically HIV-1 infected adults on virologically suppressive anti-retroviral therapy.
Barbour JD; Jalbert EC; Chow DC; Gangcuangco LM; Norris PJ; Keating SM; Heitman J; Nagamine L; Seto T; Ndhlovu LC; Nakamoto BK; Hodis HN; Parikh NI; Shikuma CM
Atherosclerosis; 2014 Jan; 232(1):52-8. PubMed ID: 24401216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
